A Comparative Study of the Clinical Benefits of Rivaroxaban and Warfarin in Patients With Non-valvular Atrial Fibrillation With High Bleeding Risk

OBJECTIVE: To compare the clinical benefits of rivaroxaban and warfarin in patients with non-valvular atrial fibrillation (NVAF) with high bleeding risk. METHODS: A retrospective study was conducted on patients with high bleeding risk NVAF who were hospitalized at the First Affiliated Hospital of Zh...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peng-Hui, Liu, Ze-Hua, Niu, Ming-Hui, Chen, Ping, Shi, Yuan-Bin, He, Fei, Guo, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888829/
https://www.ncbi.nlm.nih.gov/pubmed/35252386
http://dx.doi.org/10.3389/fcvm.2022.803233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888829/
https://www.ncbi.nlm.nih.gov/pubmed/35252386
http://dx.doi.org/10.3389/fcvm.2022.803233

Ejemplares similares